Intelligence · Clinical Development
Pipeline search results
Programs matching “advanced-solid-tumors” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 61 pipeline programs matching "advanced-solid-tumors" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Apatinib
The First People's Hospital of Lianyungang
Advanced Solid Tumors
1 trial -
BMS-986466
Bristol-Myers Squibb
Advanced Solid Tumors
1 trial -
CTX-009 (ABL001)
Compass Therapeutics
P1b: Advanced Solid Tumors
1 trial -
Daraxonrasib
Revolution Medicines
Advanced Solid Tumors
1 trial -
EIK1004-001 (IMP1707-001)
Eikon Therapeutics
Advanced Solid Tumors
1 trial -
EIK1005
Eikon Therapeutics
Advanced Solid Tumors
1 trial -
Monalizumab
MedImmune
Advanced Solid Tumors
1 trial -
PYX-201
Pyxis Oncology
Advanced Solid Tumors
1 trial -
REGN7075
Regeneron UK Limited
Advanced Solid Tumors
1 trial -
SKB103 for injection monotherapy
Sichuan Provincial People's Hospital
Advanced Solid Tumors
1 trial -
Trastuzumab deruxtecan
AstraZeneca
Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
1 trial -
indibulin
Alaunos Therapeutics
Advanced Solid Tumors
2 trials -
2X-121 and dovitinib
Allarity Therapeutics
Advanced Solid Tumors
1 trial -
ACR-2316
Acrivon Therapeutics
Specific Advanced Solid Tumors
1 trial -
ADCT-601
ADC Therapeutics SA
Advanced Solid Tumors
2 trials -
ADCT-901
ADC Therapeutics SA
Advanced Solid Tumors
1 trial -
AMT-676
Multitude Therapeutics
Advanced Solid Tumors
1 trial -
Alisertib
Takeda
Advanced Solid Tumors
7 trials -
Anti-CDH17 CAR-T cells infusion
Xiyuan Hospital of China Academy of Chinese Medical Sciences
CDH17-positive Advanced Solid Tumors
1 trial -
Atu027
Silence Therapeutics plc
Advanced Solid Tumors
1 trial -
BAY2965501
Bayer HealthCare AG
Advanced Solid Tumors
1 trial -
BC006
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Advanced Solid Tumors (Including GCTTS)
1 trial -
BEL-X-HG
Taiwan Liposome Company
Advanced Solid Tumors
1 trial -
BG-C477
BEONE MEDICINES AUS PTY LTD
Advanced Solid Tumors
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.